Show items per page
Elements: 2
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06) Koeberle, D; Betticher, D C; von Moos, R; Dietrich, D; ... Herrmann, R 2015
add to browser selection
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study Van Cutsem, E; Dirix, L; Van Laethem, J-L; Van Belle, S; ... Bleiberg, H 2005